Intention-to-treat analysis keeps all trial data, showing true drug effects, even with dropouts. It contrasts with per-protocol analysis, where dropout data is excluded, possibly skewing results.
Noninferior efficacy seen for three all-oral regimens compared with standard therapy in intention-to-treat, per-protocol populations. (HealthDay News) — Three all-oral shortened regimens have ...
Per-protocol analysis excludes noncompliant clinical trial participants' data. Mixing per-protocol with other analyses gives a clearer intervention picture. Regulators typically reject sole ...
The researchers found that 80.7% of the patients in the standard-therapy group had favorable outcomes in the modified intention-to-treat analysis. (HealthDay News) — Three all-oral shortened regimens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results